Alpine Global Management, LLC Adverum Biotechnologies, Inc. Transaction History

Alpine Global Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $27,152 - $46,994	-13,054 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.08 - $3.6 $27,152 - $46,994	13,054 New	13,054 $28,000
Q1 2018 May 16, 2018	SELL	$3.65 - $7.95 $75,602 - $164,668	-20,713 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $59,032 - $81,816	20,713	20,713 $72,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.